- Home
- RSF vs PMVP Comparison
RSF vs PMVP Comparison
Compare RSF & PMVP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
HOLD
Current Price
$1.20
Company Overview
Basic Information| Metric | RSF | PMVP |
|---|---|---|
| Founded | 2016 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 63.1M | 68.9M |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | RSF | PMVP |
|---|---|---|
| Price | $14.53 | $1.20 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $5.00 |
| AVG Volume (30 Days) | 11.8K | ★ 245.9K |
| Earning Date | 01-01-0001 | 11-12-2025 |
| Dividend Yield | ★ 10.61% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $14.81 | $0.81 |
| 52 Week High | $16.23 | $1.84 |
Technical Indicators
Market Signals| Indicator | RSF | PMVP |
|---|---|---|
| Relative Strength Index (RSI) | 54.04 | 35.08 |
| Support Level | $14.23 | $1.23 |
| Resistance Level | $14.60 | $1.36 |
| Average True Range (ATR) | 0.15 | 0.07 |
| MACD | 0.02 | -0.01 |
| Stochastic Oscillator | 100.00 | 3.57 |
Price Performance
Historical Comparison RSF
PMVP
About RSF RiverNorth Capital and Income Fund
RiverNorth Capital and Income Fund is a diversified, closed-end management investment company. Its investment objective is to seek a high level of current income by investing in credit instruments, including a portfolio of securities of specialty finance and other financial companies.
About PMVP PMV Pharmaceuticals Inc.
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. Its pipeline rezatapopt PYNNACLE, rezatapopt and azacitidine, rezatapopt (PC14586), and PMV-586-101.